Post Doctoral fellowship in BRIC-inStem for Life Sciences, Biochemistry, Biotechnology candidates
16 January 2026

Post Doctoral fellowship in BRIC-inStem for Life Sciences, Biochemistry, Biotechnology candidates

Candidates must have M.Sc. in Biochemistry, clinical Biochemistry, biotechnology/Life Sciences from a recognized university. Candidate must have submitted the PhD thesis. Institute for Stem Cell Science & Regenerative Medicine
16 January 2026
Shape your Career with Alkem Laboratories in QA, QC, Production, Warehouse
IPQA Mfg. & Packing, Shop floor activities, Review of equipment audit trails / BMR, BPR review / line clearance.
16 January 2026
Hiring DPharm, BPharm, MPharm in manufacturing department at Amneal Pharmaceuticals
To be aware and responsible for achieving quality objective and fulfilling the requirements of applicable quality procedures.
16 January 2026
Exciting opportunity for Pharma candidates to pursue their career in Clinical Research at Sami-Sabinsa Group
Exciting opportunity for candidates who are interested to pursue their career as Executive - Clinical Research in Nutraceutical Industry.
16 January 2026
Interview for MPharm, BPharm, MSc in QA, QC, Micro, Store, Production at SBL Private Limited
QA documentation, SO Ps, CA PA, change control, and compliance. QC leadership, validation, OOS/OOT, audits, and compliance.
16 January 2026
BPharm, MSc Freshers Openings in QC, Manufacturing Packing at USV Private Limited
B.Pharm, M.Sc Chemistry ; Basic knowledge of instruments HPLC, UV, IR, pH meter. Understanding of GMP, SOP, ALCOA+ principles, and Data Integrity.
16 January 2026
VerGo Pharma Hiring Scientist
Method development & validation for tablets, capsules, creams & ointments. Exposure to US/EU regulatory requirements.
16 January 2026
Sentynl Therapeutics Secures FDA approval for ZYCUBO® to Treat Menkes Disease

Sentynl Therapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ZYCUBO® (copper histidinate) for the treatment of patients with Menkes disease, a rare, inherited disorder that affects copper absorption and distribution in the body.

16 January 2026
Dr. Reddy’s Launches First-to-Market OTC Olopatadine 0.7% Eye Drops in the U.S.

Dr. Reddy’s Laboratories Ltd. announced the first-to-market launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC) in the United States, following approval from the U.S. Food and Drug Administration (USFDA). The product is the generic equivalent of Extra-Strength Pataday® (of Novartis AG) Once-Daily Relief, a leading over-the-counter antihistamine eye drop.

15 January 2026
ILBS Announces Fellowship Opportunities Under Ministry of AYUSH for Pharmacy and Life Sciences
M.Pharm / M.S Pharm. Post Graduate in Pharmacology OR Post Graduate MSc in Biomedical Sciences, Life Sciences, Physiology, Biochemistry and Biotechnology or any other relevant discipline